Literature DB >> 24140845

Dual energy computerized tomography with a split bolus-a 1-stop shop for patients with suspected urinary stones?

Michael Toepker1, Franklin Kuehas2, Daniela Kienzl3, Ralf Herwig2, Elisa Spazierer3, Bernhard Krauss4, Michael Weber3, Christian Seitz2, Helmut Ringl3.   

Abstract

PURPOSE: We evaluated a dual energy, split bolus computerized tomography protocol that provides virtual noncontrast, parenchymal and urographic phases in a single scan. We assessed the sensitivity of the virtual noncontrast phase using this protocol to detect urinary stones compared to the gold standard of the true noncontrast phase.
MATERIALS AND METHODS: We prospectively enrolled in the study 81 patients who underwent unenhanced single energy computerized tomography at 120 kV/200 mA as well as contrast enhanced dual energy computerized tomography on a Somatom® Definition Flash-CT (tube A 80 kV/233 mA and tube B SN 140 kV/180 mA with 1/0.8 mm slice thickness). For the split bolus protocol 400 mg/ml Iomeron® were injected at 2 time points, that is 15 ml 10 minutes before the scan and 80 ml 65 seconds before the scan. In a consensus reading 2 readers evaluated the presence and diameter of stones on the true and virtual noncontrast phases.
RESULTS: Of the 350 stones noted on the true noncontrast phase we found 289 on the virtual noncontrast phase as well as 13 false-positive and 66 false-negative stones. Sensitivity was 98.4%, 89.8% and 82.6% per patient, segment and stone, respectively. The diameter measured on the virtual noncontrast phase corresponded to a mean ± SD 92.5% ± 31.6% of the diameter on the true noncontrast phase. The mean effective dose was 4.8 ± 1.8 and 10.5 ± 3.7 mSv for the true and virtual noncontrast phases, respectively.
CONCLUSIONS: The proposed protocol allows for combining 3 phases in a single scan while still enabling the detection of urinary stones at high sensitivity. This technique halves the radiation dose and provides the surgeon with better anatomical information on the calyceal system. Therefore, it is a valuable diagnostic tool for kidney stone treatment planning and followup.
Copyright © 2014 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  contrast media; kidney; radiation dosage; tomography; urolithiasis; x-ray computed

Mesh:

Substances:

Year:  2013        PMID: 24140845     DOI: 10.1016/j.juro.2013.10.057

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

1.  Photon-counting CT for simultaneous imaging of multiple contrast agents in the abdomen: An in vivo study.

Authors:  Rolf Symons; Bernhard Krauss; Pooyan Sahbaee; Tyler E Cork; Manu N Lakshmanan; David A Bluemke; Amir Pourmorteza
Journal:  Med Phys       Date:  2017-08-20       Impact factor: 4.071

Review 2.  [Painless hematuria: diagnostic workup using multislice computertomography].

Authors:  M Töpker
Journal:  Radiologe       Date:  2018-10       Impact factor: 0.635

3.  Accuracy and efficiency of determining urinary calculi composition using dual-energy computed tomography compared with Hounsfield unit measurements for practicing physicians.

Authors:  Maria A Jepperson; El-Sayed H Ibrahim; Abby Taylor; Joseph G Cernigliaro; William E Haley; David D Thiel
Journal:  Urology       Date:  2014-07-15       Impact factor: 2.649

4.  Side-by-side evaluation of virtual non-contrast and post-contrast images improves detection of clinically significant urolithiasis on single-phase split bolus dual-energy CT urography.

Authors:  Doris Dodig; Tereza Solocki Matić; Iva Žuža; Ivan Pavlović; Damir Miletić; Dean Markić
Journal:  Br J Radiol       Date:  2021-04-16       Impact factor: 3.039

5.  Radiation dosing in the investigation and follow-up of urolithiasis: Comparison between historical and contemporary practices.

Authors:  Dermot O'Kane; Frank T D'Arcy; Nathan Papa; Neil Smith; Scott McClintock; Nathan Lawrentschuk; Damien M Bolton
Journal:  Investig Clin Urol       Date:  2016-02-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.